You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immunologic response to malaria vaccine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Asplenia Trial in Sacramento (Pneumovax-23)

Recruiting
  • Asplenia
  • Pneumovax-23
  • Sacramento, California
    University of California, Davis Medical Center
Jan 26, 2022

Pregnancy Related Trial (Sangobion and Thiamine Hydrochloride, Sangobion, Thiamine HCl and Vitamin B12)

Recruiting
  • Pregnancy Related
  • Sangobion and Thiamine Hydrochloride
  • Sangobion, Thiamine hydrochloride and Vitamin B12
  • Mae Sot, Tak, Thailand
    Shoklo Malaria Research Unit (SMRU)
Oct 21, 2022

(VIII): The Eight Study and Immunologic Response Sub-study

Recruiting
  • Vaccine Reaction
    • Chicago, Illinois
    • +1 more
    Feb 2, 2022

    Influenza, Human, Immune Response Trial in Pittsburgh (FluMist live attenuated influenza vaccine, Flucelvax inactivated

    Completed
    Has Results
    • Influenza, Human
    • Immune Response
    • FluMist live attenuated influenza vaccine
    • Flucelvax inactivated influenza vaccine
    • Pittsburgh, Pennsylvania
    • +1 more
    Sep 17, 2021

    COVID19 Vaccination in Immunodeficient Patients

    Active, not recruiting
    • Multiple Sclerosis
    • +2 more
    • COVID19 vaccine
    • New Haven, Connecticut
      Yale University
    May 9, 2022

    Malaria Trial in Silver Spring (DNA vaccine prime, adenovirus type 5 vaccine boost)

    Completed
    • Malaria
    • DNA vaccine prime
    • adenovirus type 5 vaccine boost
    • Silver Spring, Maryland
      Clinical Trials Center, WRAIR
    Feb 10, 2021

    Malaria, Malaria,Falciparum, Parasitic Disease Trial in Oxford (RH5.1 and/or RH5.2-VLP with Matrix-M)

    Not yet recruiting
    • Malaria
    • +4 more
    • RH5.1 and/or RH5.2-VLP with Matrix-M
    • Oxford, Oxfordshire, United Kingdom
      Centre for Clinical Vaccinology & Tropical Medicine (CCVTM)
    Jul 27, 2023

    Malaria, Malaria,Falciparum, Protozoan Infections Trial in Sheffield (Matrix M with RH5.1)

    Recruiting
    • Malaria
    • +5 more
    • Matrix M with RH5.1
    • Sheffield, United Kingdom
      Sheffield Teaching Hospitals, Royal Hallamshire Hospital
    Nov 14, 2023

    Host and Parasite Factors That Influence Susceptibility to

    Recruiting
    • Malaria
      • Bamako, Mali
      • +1 more
      Jan 18, 2023

      Malaria,Falciparum Trial in Bangkok (R21/Matrix-M vaccination, DHA-PIP, PQ)

      Not yet recruiting
      • Malaria,Falciparum
      • R21/Matrix-M vaccination
      • +2 more
      • Bangkok, Thailand
        Hospital for Tropical Diseases, Faculty of Tropical Medicine, Ma
      Feb 22, 2022

      Malaria Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Pvs230D1-EPA/Matrix-M)

      Not yet recruiting
      • Malaria
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jun 28, 2023

      Malaria,Falciparum Trial in Bamako (MSP3-CRM-Vac4All/ Alhydrogel®, Anti-Rabies Vaccine)

      Not yet recruiting
      • Malaria,Falciparum
      • MSP3-CRM-Vac4All/ Alhydrogel®
      • Anti-Rabies Vaccine
      • Bamako, Mali
        Malaria Research and Training Center (MRTC), University of Scien
      Mar 7, 2023

      Malaria Trial in Bagamoyo (SumayaVac-1(SUM-101), Verorab, CHMI)

      Not yet recruiting
      • Malaria
      • SumayaVac-1(SUM-101)
      • +2 more
      • Bagamoyo, Tanzania
        Ifakara Health Institute
      Dec 1, 2022

      Following COVID-19 Vaccination in Children, Adolescents, and

      Recruiting
      • COVID-19 Infection
      • +2 more
      • Biospecimen Collection
      • Survey Administration
      • Birmingham, Alabama
      • +54 more
      Jan 30, 2023

      Plasmodium Falciparum Trial in Kisumu (RTS,S/AS01E, Abhayrab rabies vaccine)

      Active, not recruiting
      • Plasmodium Falciparum
      • RTS,S/AS01E
      • Abhayrab rabies vaccine
      • Kisumu, Kisumu County, Kenya
        Kombewa Clinical Research Center
      Oct 7, 2021

      Malaria,Falciparum Trial in Bamako (Pfs230D1-EPA/Matrix-M Vaccine, Verorab Rabies Vaccine)

      Active, not recruiting
      • Malaria,Falciparum
      • Pfs230D1-EPA/Matrix-M Vaccine
      • Verorab Rabies Vaccine
      • Bamako, Mali
        Malaria Research Training Center
      Sep 7, 2022

      Malaria,Falciparum Trial in Sigle (Rabies vaccine, RH5.1 10µg adjuvated with 50µg Matrix-M, RH5.2 5µg adjuvated with 50µg

      Recruiting
      • Malaria,Falciparum
      • Rabies vaccine
      • +2 more
      • Sigle, Boulkiemdé Province, Burkina Faso
        Institut de Recherche en Sciences de la Santé
      Apr 3, 2023

      Plasmodium Vivax Infection, Malaria Vaccine Trial in Bangkok (Malaria Vaccine, HBV vaccine)

      Not yet recruiting
      • Plasmodium Vivax Infection
      • Malaria Vaccine
      • Malaria Vaccine
      • HBV vaccine
      • Bangkok, Thailand
        Faculty of Tropical Medicine
      Jan 16, 2023

      Malaria Trial in Ou(SqrRoot)(Copyright)less(SqrRoot)(Copyright)bougou (biological, other, drug)

      Suspended
      • Malaria
      • PfSPZ Vaccine
      • +2 more
      • Ou(SqrRoot)(Copyright)less(SqrRoot)(Copyright)bougou, Mali
        Ou(SqrRoot)(Copyright)less(SqrRoot)(Copyright)bougou, Health Res
      Feb 2, 2023

      Pregnancy Malaria Vaccine Candidates/In-vitro Testing of

      Recruiting
      • Malaria
        • Bamako, Mali
          Ouelessebougou Clinical Research Center
        Jul 6, 2022

        Naturally Acquired Malaria Immunity in Mali

        Completed
        • Malaria
          • Bamako, Mali
            University of Bamako, Faculty of Medicine, Pharmacy and Odontost
          Mar 29, 2022

          Malaria, Plasmodium Falciparum Trial (Matrix-M with RH5.2 VLP and/or R21)

          Not yet recruiting
          • Malaria, Plasmodium Falciparum
          • Matrix-M with RH5.2 VLP and/or R21
          • (no location specified)
          Oct 21, 2022

          Immunocompromised Patients Trial in Switzerland (Moderna COVID-19 Vaccine, mRNA-1273 (100 µg), Pfizer-BioNTech COVID-19 Vaccine

          Active, not recruiting
          • Immunocompromised Patients
          • Moderna COVID-19 Vaccine, mRNA-1273 (100 μg)
          • Pfizer-BioNTech COVID-19 Vaccine BNT162b2 (30 µg)( Comirnaty®)
          • Basel, Switzerland
          • +3 more
          Oct 18, 2022

          COVID-19 Trial in United States (drug, biological, other)

          Active, not recruiting
          • COVID-19
          • Birmingham, Alabama
          • +21 more
          Feb 2, 2023

          Malaria Trial in Oshogbo (Perennial Malaria Chemoprevention effect)

          Active, not recruiting
          • Malaria
          • Perennial Malaria Chemoprevention effect
          • Oshogbo, Osun, Nigeria
            Ministry of Health
          Nov 30, 2023